The bone disorder known as idiopathic osteonecrosis of the femoral head (ONFH) might be caused by high-dose steroid therapy —…
Articles by Magdalena Kegel
XTL Biopharmaceuticals has completed the design of a Phase 2 clinical trial investigating its drug candidate hCDR1 for systemic lupus erythematosus…
Clinical management of systemic lupus erythematosus (SLE) is challenging, and aims mainly to slow or prevent organ damage, particularly kidney…
The excessive inflammatory response that is characteristic of systemic lupus erythematosus (SLE) has now been shown by scientists at University College London to be…
A nutritious diet likely helps protects against lupus flare-ups, but contrary to what other studies have indicated, Vitamin D does not…
Researchers from Singapore’s leading science institute, A*STAR, found that a group of small noncoding RNAs, called mir-17-92, regulate B-cell function and antibodies…
Resolve Therapeutics has successfully completed a dose escalation study of its candidate drug RSLV-132 targeting systemic lupus erythematosus (SLE). RSLV-132…
Researchers investigating how diet affects disease activity in systemic lupus erythematosus (SLE) patients, determined via glucocorticoid (GC) treatment, found that dietary vitamin…
A recent study revealed that mitochondria induce inflammation in lupus through the release of reactive oxygen species into neutrophil extracellular…
A study from the Scripps Research Institute shows that harmful autoimmune…